Advertisement
EXPE vs WW
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXPE is a StrongBuy and WW is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EXPE’s FA Score shows that 1 FA rating(s) are green whileWW’s FA Score has 1 green FA rating(s).
- EXPE’s FA Score: 1 green, 4 red.
- WW’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EXPE’s TA Score shows that 6 TA indicator(s) are bullish while WW’s TA Score has 5 bullish TA indicator(s).
- EXPE’s TA Score: 6 bullish, 3 bearish.
- WW’s TA Score: 5 bullish, 4 bearish.
Price Growth
EXPE (@Consumer Sundries) experienced а +4.72% price change this week, while WW (@Hospital/Nursing Management) price change was -1.78% for the same time period.
The average weekly price growth across all stocks in the @Consumer Sundries industry was +0.62%. For the same industry, the average monthly price growth was +7.70%, and the average quarterly price growth was -2.47%.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +3.88%. For the same industry, the average monthly price growth was +11.59%, and the average quarterly price growth was +38.08%.
Reported Earning Dates
EXPE is expected to report earnings on Jul 30, 2026.
WW is expected to report earnings on Jul 30, 2026.
Industries' Descriptions
@Consumer Sundries (+0.62% weekly)Consumer sundries companies make products that usually do not have another classification, such as lawn and garden products, pest-control products, pet food and pet products like leashes, collars, and harnesses. Central Garden & Pet Company and Dogness (International) Corporation are examples of companies operating in this industry.
@Hospital/Nursing Management (+3.88% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| EXPE | WW | EXPE / WW | |
| Capitalization | 32.2B | 163M | 19,755% |
| EBITDA | 3.08B | 1.15B | 267% |
| Gain YTD | -6.841 | -45.268 | 15% |
| P/E Ratio | 21.03 | 1.57 | 1,339% |
| Revenue | 15.2B | 741M | 2,051% |
| Total Cash | 5.79B | 121M | 4,788% |
| Total Debt | 4.71B | 468M | 1,006% |
EXPE | WW | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 86 Overvalued | 80 Overvalued | |
PROFIT vs RISK RATING 1..100 | 60 | 100 | |
SMR RATING 1..100 | 9 | 9 | |
PRICE GROWTH RATING 1..100 | 43 | 63 | |
P/E GROWTH RATING 1..100 | 45 | 84 | |
SEASONALITY SCORE 1..100 | 50 | 45 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
WW's Valuation (80) in the Other Consumer Services industry is in the same range as EXPE (86). This means that WW’s stock grew similarly to EXPE’s over the last 12 months.
EXPE's Profit vs Risk Rating (60) in the Other Consumer Services industry is somewhat better than the same rating for WW (100). This means that EXPE’s stock grew somewhat faster than WW’s over the last 12 months.
EXPE's SMR Rating (9) in the Other Consumer Services industry is in the same range as WW (9). This means that EXPE’s stock grew similarly to WW’s over the last 12 months.
EXPE's Price Growth Rating (43) in the Other Consumer Services industry is in the same range as WW (63). This means that EXPE’s stock grew similarly to WW’s over the last 12 months.
EXPE's P/E Growth Rating (45) in the Other Consumer Services industry is somewhat better than the same rating for WW (84). This means that EXPE’s stock grew somewhat faster than WW’s over the last 12 months.
| EXPE | WW | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 67% | 3 days ago 90% |
| Stochastic ODDS (%) | 3 days ago 64% | 3 days ago 84% |
| Momentum ODDS (%) | 3 days ago 81% | 3 days ago 90% |
| MACD ODDS (%) | 5 days ago 81% | 3 days ago 90% |
| TrendWeek ODDS (%) | 3 days ago 73% | 3 days ago 90% |
| TrendMonth ODDS (%) | 3 days ago 76% | 3 days ago 90% |
| Advances ODDS (%) | 11 days ago 73% | 17 days ago 81% |
| Declines ODDS (%) | N/A | 9 days ago 90% |
| BollingerBands ODDS (%) | 3 days ago 60% | 3 days ago 76% |
| Aroon ODDS (%) | 3 days ago 79% | 3 days ago 69% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ETHSX | 13.60 | 0.39 | +2.95% |
| Eaton Vance Worldwide Health Sci A | |||
| FBTAX | 46.20 | 1.17 | +2.60% |
| Fidelity Advisor Biotechnology A | |||
| BROCX | 24.25 | 0.34 | +1.42% |
| BlackRock Advantage International Inv C | |||
| JHAAX | 10.75 | 0.01 | +0.09% |
| JHancock Multi-Asset Absolute Return A | |||
| EVCGX | 15.90 | -0.26 | -1.61% |
| Eaton Vance China Equity A | |||
WW and
Correlation & Price change
A.I.dvisor tells us that WW and SABR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WW and SABR's prices will move in lockstep.